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Abstract
Background: The cost of RNA-Seq has been decreasing over the last few years. Despite this, experiments with four
or less biological replicates are still quite common. Estimating the variances of gene expression estimates becomes
both a challenging and interesting problem in these situations of low replication. However, with the wealth of
microarray and other publicly available gene expression data readily accessible on public repositories, these sources
of information can be leveraged to make improvements in variance estimation.
Results: We have proposed a novel approach called Tshrink+ for inferring differential gene expression through
improved modelling of the gene-wise variances. Existing methods share information between genes of similar
average expression by shrinking, or moderating, the gene-wise variances to a fitted common variance. We have
been able to achieve improved estimation of the common variance by using gene-wise sample variances from
external experiments, as well as gene length.
Conclusions: Using biological data we show that utilising additional external information can improve the
modelling of the common variance and hence the calling of differentially expressed genes. These sources of
additional information include gene length and gene-wise sample variances from other RNA-Seq and microarray
datasets, of both related and seemingly unrelated tissue types. The results of this are promising, with our
differential expression test, Tshrink+, performing favourably when compared to existing methods such as DESeq
and edgeR when considering both gene ranking and sensitivity. These improved variance models could easily be
implemented in both DESeq and edgeR and highlight the need for a database that offers a profile of gene
variances over a range of tissue types and organisms.
Background
In the post-genomic era, the development of technologies
for sequencing the genome and transcriptome has become
a key issue in the global analysis of biological systems.
Even with the lowering cost of sequencing data, the major-
ity of RNA-Seq experiments are still suffering from low
replication numbers. The identification of differential
expressed (DE) genes and transcripts is still a key question
of interest in many biological studies. To date, there are
many methods that provide a test of whether a gene is DE
or not [1], including cufflinks [2], DESeq [3] and edgeR
[4]. A feature in all of these methods is moderation of
gene-wise variance estimates to improve DE inference.
Moderation is important in small samples size compari-
sons, increasing both the power and accuracy of a DE test
[5]. The key differences between these methods are the
extent of the moderation and their common variance esti-
mate–the variance estimate that the procedure is moderat-
ing towards.
DESeq and edgeR account for the heteroscedasticity
observed in the read counts of genes by modelling the
relationship between expected value of the count and its
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variability. We propose using additional information,
such as gene length and variance estimates from external
datasets, as explanatory variables to further model the
heterogeneity seen in the observed gene variances. Com-
bining these improved models of gene variance with a
moderation method [6] creates a robust tool for estimat-
ing gene variances and hence calling differential gene
expression. When evaluated on publicly available data
this tool offers both improved gene ranking and power of
detection when compared to DESeq and edgeR. This
method is implemented in the R package sydSeq available
on http://www.maths.usyd.edu.au/u/jeany/software.htm.
RNA-Seq
The development of high throughput sequencing tech-
nologies has made it possible to sequence the transcrip-
tome at a much higher resolution and coverage than
was previously available. Sequencing of cDNA samples
(RNA-Seq) has a dynamic range larger than that of
microarrays [7]. This, combined with its high level of
reproducibility [8] and falling cost, makes high through-
put sequencing technologies an increasingly attractive
alternative to microarrays for transcriptome analysis. In
the following we will describe how variances are esti-
mated for RNA-Seq data with small samples sizes.
A typical RNA-seq data analysis work flow consists of
many steps. These steps generally consist of mapping,
summarisation, normalisation, differential expression
analysis and systems biology [9]. The summarisation
step counts how many reads were mapped to each gene
or transcript. We will consider the case of mapping to
genes rather than transcripts, so for us summarisation
results in a matrix of counts, where the rows and col-
umns correspond to genes and samples respectively.
Let yij be the observed read count for the i
th gene in
the jth sample where sample j belongs to treatment t(j)
= 1, 2. Let σ 2i and μi be the variance and mean read
count for gene i. For ease of presentation we will
assume that all effects that are generally normalised for
or modelled, such as library sizes and GC content,
remain constant across samples. The technical variability
for a gene count in RNA-Seq can be modelled quite
reliably as Poisson [10,11]. This is attractive in situations
of low replication as one parameter can be estimated to
describe both the mean and variance of a gene. Model-
ling the data as Poisson will give a very reliable estimate
of which genes have changed in expression between any
two samples. However many experiments are not simply
focused on the detection of gene expression differences
between any two samples focusing instead on the differ-
ences between any two types of cells for example. This
distinction is important as it requires us to not only
model the technical variability of the experiment but to
also model the biological variability of a particular cell
type (or experimental condition).
An over-dispersed Poisson, a discrete distribution with
dispersion greater than a Poisson, can be modelled
using a Negative Binomial. A negative binomial random
variable, Y , can be parametrised as
P(Y = y) =
(




This standard formulation is generally referred to as
NB2. Under this formulation, the biological variability of
the expression of a gene is modelled as a quadratic
function of its mean expression μ:
σ 2 = μ + bμ2, (2)
where as b = 1r gets small the negative binomial will
approach a Poisson. The parameter b has been referred
to as the coefficient of biological variation. A negative
binomial is generally parametrised as a function of r and
p. However, by parametrising a negative binomial in
terms of its mean μ and variance s2 where
r =
μ2





and s2 >μ, a negative binomial can then be used to
model counts that have untraditional mean-variance
relationships. This relationship is generally expressed as
σ 2 = μ + f (μ) (5)
where f(μ) explains the biological variability can be
fitted by some form of local regression [3]. This formu-
lation of s2 highlights that s2 should always be greater
than or equal to μ.
In current RNA-Seq experiments it is still quite com-
mon to see experiments with very little biological repli-
cation. Estimating variances from few observations is
unstable [12]. To improve the stability and accuracy of
these variance estimates there have been many methods
proposed to shrink the variances to some common
value for microarrays [12] and RNA-Seq [1]. We will
refer to this as moderation. By stabilising the variances
and sharing information moderation also increase the
power of a statistic as this increases the degrees of free-
dom of a variance estimate [5].
Heterogeneous gene variances
It is well accepted that some genes have a higher var-
iance than other genes [13]. That is, some genes vary in
expression more from cell to cell, person to person, or
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treatment to treatment than other genes. In RNA-Seq
datasets, genes with larger average expression have on
average larger observed variances. Instead of shrinking
the estimate of a genes variance towards some common
value (as is often done in microarrays) to improve stabi-
lity [12], edgeR and DESeq shrink the estimate towards
some fitted curve describing the relationship between
mean and variance. We refer to this fitted curve as the
common variance. In doing this they are making the
strong assumption (although not an unreasonable one)
that genes with a similar average count should have a
similar variance.
We incorporate external data from RNA-Seq and
microarrays on mouse striatum and RNA-Seq data from
different tissues to better estimate variances and hence




We propose using local regression [14] to fit a
smoothed surface through any number of variables (g(1),
g(2) ...) that may help to explain the observed pooled
sample variances σˆ 2gene = s
2. We estimate the common
variances σ 2common as
σˆ 2common = μ + f
(
μ, γ(1), γ(2), ..
)
. (6)
When using variance estimates from other RNA-Seq
experiments, these variances will also have a very strong
mean-variance relationship. For use as an explanatory vari-
able we normalise the external variance estimates in such
a way that they have mean zero and variance one for all
ranges of expression.
To illustrate how this improved common variance can
aid in moderation we propose using a quasi-empirical
Bayes moderation method [6], where the variance is
moderated as
σˆ 2shrink = λσˆ
2
common + (1− λ)σˆ 2gene, (7)
and ˆσ 2shrink, ˆσ 2common and ˆσ 2gene are the moderated, com-
mon and sample variances. Without making distribu-
tional assumptions, the shrinkage parameter l can be




















l is the ratio of the expected and average squared
error of the common variance estimate. Due to the large
amount of smoothing that is used in estimating the
common variance, we will make the assumption that the
data, standardised using the common variance estimate,
is approximately standard normal. Under this assump-
tion the variance of σ 2k(gene)/σ
2
k(common) which has n - 2





(n− 2)∑k=1 (σˆ 2k(gene)/σˆ 2k(common) − 1)2
⎞
⎟⎠ . (9)












where we utilise the Welch-Satterthwaite equation
[15,16] to estimate its degrees of freedom vˆ. We have
assumed earlier that that the degrees of freedom corre-
sponding to common variance is νcommon = ∞ and can
thus estimate vk as
vˆk =
(






where νgene = n - 2. For simplicity, rather than using a
different v for each gene we instead use one degrees of




The Bottomly data [17] was used as the main analysis
dataset for evaluation and was chosen because of its
relatively large number of biological replicates. The pre-
processed RNA-Seq data comparing ten C57BL/6J (B6)
and eleven DBA/2J (D2) mouse striatum was downloaded
from the ReCount project [18] as a matrix of counts. For
simplicity only the first ten DBA/2J samples were used. All
data used in the analysis are normalised counts as DESeq
and edgeR do not accept gene-wise normalisation factors.
To model the disparate library sizes and biases of PCR
amplification observed in the data, a cyclic robust linear
model was used. Using the first sample in the dataset as a
reference, M values were calculated for each gene in the
remaining samples and a straight line was fitted through
the M-values using GC-content as an explanatory variable.
The M-values were then normalised to this line such
that the average M-value was zero over the range of GC-
content. After this normalisation there were still batch and
other sample specific effects evident in the data. These
were normalised out using a cyclic loess [19] strategy
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as described in Additional File 1. This normalisation
appeared to be more suitable than RUV [20] and SVA [21]
improving concordance with microarray results as seen in
Additional Figures 1 and 2 in Additional File 1 .
External datasets
Sample variances from three datasets were used as
sources of additional information to aid in the estima-
tion of the common variance. These are described in
Table 1. All RNA-Seq data were mapped to the mm9
mouse genome using bowtie [22] and normalised for
GC content bias and library size differences as the Bot-
tomly dataset was. The microarray data were read and
processed using the R packages Affy [23] and gcrma
[24].
Evaluation study
In this study, we evaluate our proposed method of improv-
ing variance estimation for differential gene expression
analysis, Tshrink+. This evaluation consists of two compo-
nents, assessing the capacity of a common variance esti-
mate to explain the observed gene sample variances and
evaluating how improving this common variance estimate
can aid in the detection of differentially expressed genes.
The performance of Tshrink+ will also be compared with
two commonly used packages, edgeR and DESeq. This
evaluation study is built upon one main dataset, the Bot-
tomly data, and three datasets which are used for addi-
tional information.
In order to assess the capacity of a common variance
estimate to explain the observed gene sample variances we
will use the shrinkage coefficient l, described in the meth-
ods section, as a statistic. l is the ratio of the expected and
average squared error of the common variance estimate.
We aim to assess the effectiveness of using information in
addition to the average expression of a gene to estimate a
common variance function. Variance estimates from the
external datasets described in Table 1 and also gene length
are used to aid in the estimation of the common variance
functions of one hundred random comparisons of n sam-
ples of B6 mouse striatum tissue with n samples of D2
mouse striatum tissue. This is performed for one additional
dataset at a time. The average l value is calculated for each
n comparison and information source using only the genes
that are present in all data sources.
We then further demonstrate that improving the
information content of an additional information source
improves the estimation of the common variance. This
will be achieved by using variance estimates from the
D2 mice to aid in the estimation of a common variance
function of the B6 mice. The variance estimates from a
random n D2 mouse samples are used to estimate the
common variance function of a random four B6 mouse,
this is repeated one hundred times and average l values
are calculated.
We will assess the influence of using additional infor-
mation and moderation on the detection of differentially
expressed (DE) genes. To do this we compare
1. a t-test (T),
2. a moderated t-test (Tshrink) and
3. a moderated t-test using additional information
(Tshrink+).
These will also be compared to
4. DESeq using only the common variance
(DESeqCommon),
5. DESeq using the maximum of the common var-
iance and sample variance (DESeqMax) and
6. edgeR using a trended common variance and
empirical Bayes to shrink the gene sample variances
towards the common variance (edgeR).
To assess the effectiveness of the six DE methods, a
standard t-test was performed comparing ten B6 and
ten D2 mouse striatum samples. In all of the following,
the results of this t-test are taken to be the “truth”.
From this t-test a gene is conservatively called “truly”
DE if it has a Bonferroni adjusted p-value of less than
0.05. A gene is called “truly” not DE if it has an unad-
justed p-value greater than 0.05. We will then evaluate
the ability of the DE methods to recover the information
Table 1 Additional information sources.
Species Tissue Replicates Platform Source GEO accession
Liver 6
Spleen 6




C57BL/6J mouse Striatum 4 RNA-Seq Polymenidou et al. (2011) [27] GSE27218
C57BL/6J mouse Striatum 10 microarray Bottomly et al. (2011) [17] GSE26024
Variance estimates from these three datasets are be used to improve the estimation of the common variance function in the main analysis dataset.
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in the comparison of ten B6 samples with ten D2 sam-
ples by smaller comparisons of n B6 samples and n D2
samples, for n ranging from two to five. This is done by
comparing a random set of n B6 and n D2 mouse stria-
tum samples one hundred times and then
• generating Receiver Operator Curves (ROC, a
curve describing each methods True Positive Rate as
a function of its False Positive Rate for a complete
range of p-value cut-offs),
• calculating partial areas under the ROC for FPR
less than 0.01 and
• calculating True Positives (TP) and False Positives
(FP) using a Bonferroni adjusted p-value cut-off of 0.05.
Results and discussion
The estimation of the common variance
We begin by examining the effect of using information
from different additional sources to help explain the
variances observed in the Bottomly Data. That is, assessing
the impact that each of the additional datasets in Table 1
can have on estimating the pooled variances of n B6 vs n
D2 mouse striatum comparisons. Thus we only consider
one additional dataset at a time and do not consider how
they could interact. When used to help fit the common
variance surface, using information from any of the addi-
tional data sources improve the estimate of the common
variance as seen in Figure 1. This is observed through all
of the average l’s being higher when using additional
information when compared to using only the mean. l is
proportional to the reciprocal of the average squared error
of the variance estimates, thus a larger l corresponds to a
better estimate of the common variance. A l value of one
implies that the common variance is representative of the
population variance. A l of zero suggests that the com-
mon variance estimate is failing to describe the observed
gene sample variances.
The more relevant the information contained in the
additional data source, the greater the improvement seen
Figure 1 Effect of utilising different sources of information on the estimation of l. Variance estimates from the external datasets (Table 1)
and gene length are used to aid in the estimation of the common variance functions of one hundred comparisons of n B6 and n D2 mouse
striatum samples. The average l value is plotted for each n comparison and information source for n ranging from two to five. l is the ratio of
the expected and average squared error of the gene sample variance to the common variance. The information source “None” corresponds to
using no extra information, “Striatum” the RNA-Seq samples from Polymenidou et al (2011) and “Striatum Microaray” the microarray striatum
samples from Bottomly et al (2011). The information sources have been sorted by their l values for n equals two.
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in the common variance estimate. As is perhaps expected
either of the two striatum tissue datasets, RNA-Seq and
microarray, when used to estimate the common variance
produce the largest l, with microarray striatum and RNA-
Seq striatum only slightly out performing hippocampus.
Spleen and lung both also increase l highlighting that
information can still be gained from unrelated tissue types,
however, liver and heart barely increase l at all. This can
mostly be explained by the use of liver and heart resulting
in the variance of one gene, transthyretin, being severely
under-estimated. If this gene is excluded the l generated
by using liver and heart are much similar to that of spleen
and lung. Including information on gene length also has
the potential to improve variance information however
this appears to relatively decrease as the sample size
n increases.
Improving the accuracy of the sample variance decreases
l and improving the accuracy of the common variance
increases l. As the sample size n increases, l decreases.
This is because as n increases the accuracy of the gene
sample variance estimates increase. As the estimation of
the gene sample variances improves, the inability of the
common variance to describe the gene variances becomes
more clear. The converse of this is seen in Table 2. As the
information content of the additional data source
improves, variance estimates from D2 mice calculated
with increasing sample sizes, the ability of the common
variance to describe the observed gene variances, calcu-
lated from four replicates of B6 mice, also improves. l is
doubled by using ten replicates of D2 mouse as opposed
to nothing, that is, the average squared error of the com-
mon variance is halved.
The impact of moderation on inferring differential
expression
The aim of the remainder of the evaluation is to assess
how the use of moderation affects inference on differen-
tial gene expression. This is done by assessing the
impact of moderation on both gene ranking and sensi-
tivity. Moderation is used to both increase the sensitivity
of a test, by increasing the degrees of freedom of the
variance estimate, and to improve the ranking of a test,
by improving the accuracy of the variance estimate.
We will start by simply comparing the t-test (T), mod-
erated t-test (Tshrink) and a moderated t-test using
additional information (Tshrink+). For the additional
data source used by Tshrink+, the four striatum RNA-
Seq samples [25] in Table 1 were chosen as they gave
the second highest value but were not generated from
the same lab as the analysis dataset (as the microarray
data were).
By first considering only four vs four comparisons, the
ability of moderation to improve gene ranking is illustrated
in Figure 2a where a partial average ROC curve from one
hundred four vs four comparisons of B6 and D2 mouse
striatum is plotted for each method. This curve shows
each methods TPR for a range of FPR, where a method is
deemed to have ranked genes better than another at a
given FPR if its TPR is higher. Here we see that Tshrink
(dark blue) performs better than T (light blue) for all FPR
less than 0.01. Tshrink+ (red) offers a similar improve-
ment again on top of that of Tshrink nearly doubling the
improvement of Tshrink to T.
Moderation improves gene ranking and improving what
a method moderates too can improve gene ranking
further. This is again illustrated in Figure 3a, where the
partial area under the ROC curve is plotted for a range of
n vs n comparisons. A value of 1 corresponds to a perfect
ranking and a value of zero corresponds to the most
imperfect ranking. For all n considered Tshrink+ appears
to double the improvement of Tshrink when compared to
T. The relative improvements decrease as n increases as
the information in the sample variance increases in com-
parison to the common variance.
Moderation can improve the sensitivity of a test for dif-
ferential expression as seen in Figure 2b. Figure 2b plots
the average number of True Positive genes called at vary-
ing p-value cut-offs for one hundred four vs four tests. At
a Bonferroni adjusted p-value cut-off of 0.05 (the grey
dashed line) T calls 8 TP, Tshrink 47 TP and Tshrink+
108 TP. These improvements are seen at very little cost
the the number of False Positives called. The number of
TP and FP called at a Bonferroni adjusted p-value cut-off
of 0.05 for n ranging from two to five are plotted in
Figures 3b and 3c respectively. Here we see the number of
TP called for Tshrink+ increases as n increases and the
number FP decreasing as n increases. While the number
of TP called also increase for T, it decreases for Tshrink
over this range of n. The number of TP called by Tshrink
will decrease until Tshrink converges to T when it will
continue to increase. Tshrink may be over-zealous in its
calling of TP calling a relatively large amount of FP as well
for small n.
Comparison with edgeR and DESeq
Tshrink+ performs favourably when compared to both
DESeq and edgeR when considering gene ranking. When
assessing gene ranking using Figure 3a, Tshrink+ performs
marginally better than DESeqMax (green) which is better
Table 2 Using D2 variance estimates to estimate common
variance of four B6 samples.
n D2
samples
0 2 3 4 5 6 7 8 9 10
l 0.35 0.45 0.50 0.55 0.58 0.65 0.68 0.72 0.75 0.77
The average l values calculated using a random n D2 mouse striatum
samples to estimate the variance of a random four B6 mouse striatum
samples from one hundred simulations.
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than edgeR (black) and DESeqCommon (pink). The rela-
tive performance of Tshrink+ over DESeqMax increases
as n increases. For n equal to five edgeR performs worse
than T. It could be argued that this is because T is becom-
ing closer to the t-test that was used as “truth”, however
this behaviour is also observed when using the results
from microarray array data [17] as “truth” as seen in
Supplementary Figure 4 in Additional File 1. This is per-
formance could also be explained by edgeR over moderat-
ing to a common variance that is become decreasingly
relevant as n increases.
Tshrink+ compares comparably to edgeR and DESeq
when assessing sensitivity. T selects a similar number of
TP at the cut-off when compared edgeR but selects less
Figure 3 Partial AUCs and the number of True and False Positives for a range of n vs n comparisons. One hundred random comparisons
of n B6 and n D2 mouse striatum samples a performed for six DE methods for n ranging from two to five. For each method and n, (a) partial
areas under the ROC curves (partial AUC) are calculated for the regions of FPR less than 0.01 and for the conservative Bonferroni adjusted cut-off
of 0.05 the average number of (b) True Positives and (c) False Positive are counted.
Figure 2 Comparing six DE methods on a 4 vs 4 comparison. One hundred random comparisons of four B6 and four D2 mouse striatum
samples for six DE methods. Average TP and FP are calculated for the full range of p-value cut-offs. The TPR and FPR are plotted against each
other in a) to form ROC curves and displayed in the region for FPR less than 0.01 as this is most relevant for calling DE. For any given FPR a
method with a larger TPR is deemed to have ranked the genes better. In b) the number of TP (in bold) and FP are plotted for a range of p-
value cut-offs. The x-axis is in log-scale. The grey dashed vertical line corresponds to a Bonferroni adjusted cut-off of 0.05.
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FP as seen in Figures 3b and 3c. While DESeqMax does
not select as many TP for the given cut-off as DESeqCom-
mon it selects dramatically less FP.
Conclusions
Using additional information improves the estimation of
the common variance and the detection of differentially
expressed genes. Our differential expression test,
Tshrink+ which incorporates information from addi-
tional datasets, showed marked improvement in both
gene ranking and sensitivity over a moderated t-test,
Tshrink, and a standard t-test, T. Tshrink+ also per-
formed favourably against edgeR and DESeq when com-
paring gene ranking and comparably when assessing
sensitivity.
Whilst Tshrink+ can offer improvements to a differ-
ential expression analysis it also provides insight into
avenues for further research. The moderation used in
Tshrink+ [6] can be drastically affected by genes with
unusual variances. A more sophisticated methodology
which manages the influence of these genes on mod-
eration could offer potentially large improvements.
While using local regression to t the common variance
when incorporating one additional dataset is easy to
implement, it does not scale well to the use of multi-
ple information sources. A parametric based approach
may make the integration of multiple data sources
feasible.
This methodology should be considered as a comple-
ment, not a replacement, for meta-analysis when similar
studies to the RNA-Seq study of interest exist. Tshrink+
leverages only the variance estimates from external data-
sets to improve the variance estimation in the study of
interest. If information exists on the changes of expres-
sion between conditions as well, a researcher may be
remiss to not utilise this information through the use of
existing meta-analysis methodologies.
Using external data to improve the estimation of the
common variance for a particular problem highlights the
significance of access to public data repositories like the
gene expression omnibus (GEO) [26]. These repositories
have the ability to actualise improved inference lending
both confidence and power to results. Projects like
ReCount [18] aid in this process by providing access to
pre-processed data that avoids the duplication of the
computationally intensive procedure of both download-
ing and processing large datasets.
Additional material
Additional file 1: Additional file 1 includes a description of the
normalisation used in the evaluation and additional figures.
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